The poster “Risk of Major Osteoporotic Fracture (Hip, Vertebral, Radius, Humerus [MOF]) After First, Second and Third Fragility Fracture In A Swedish General Population Cohort”, co-authored by Emma Jonsson, Oskar Ström, Fredrik Borgström and Jonas Banefelt of Quantify, received […]
While the UK is preparing to leave the European stage, 19 countries are lining up to host the prestigious European Medicines Agency (EMA), currently based in London. Sweden hopes to welcome the agency with its 900 employees in Stockholm, but […]
We have compiled a list of useful blogs and resources, which may help you stay on top of the evolving world of health economics and outcomes research. It’s by no means a complete list, we will be adding interesting new […]
Quantify will be well-represented at this year’s European ISPOR congress, which is held in Glasgow, Scotland. We will be presenting some of our latest research and display our company in the exhibition hall.
We welcome the opportunity to meet with you! […]
Quantify will be represented at EUROSPINE 2017 in Dublin 11-13 October 2017. Emma Jonsson will present two posters, titled “Surgical outcome categorisation using global assessment (GA)” and “Cost of low back pain: results from a register study in […]
The paper “Exploring methods for comparing the real-world effectiveness of treatments for osteoporosis: adjusted direct comparisons versus using patients as their own control” has been published in Archives of Osteoporosis. Linda Karlsson, Johan Mesterton, and Oskar Ström of Quantify are […]
The paper “A health economic lifetime treatment pathway model for low back pain in Sweden” has been published in the Journal of Medical Economics. Quantify’s Gylfi Olafsson, Emma Jonsson, and Fredrik Borgström are among the co-authors of the paper. […]
The abstract “The treatment gap after fracture in osteoporosis patients in Sweden”, co-authored by Jonas Banefelt, Linda Karlsson, Gustaf Ortsäter, and Oskar Ström of Quantify, was selected as a top 6 poster presentation at the 6th Global Congress of The […]
The paper “Real-world costs of autosomal dominant polycystic kidney disease in the Nordics” has been published in BMC Health Services Research. Linda Karlsson and Oskar Eklund of Quantify Research are among the co-authors of the paper. Pubmed link
Quantify has reviewed the new guidance on reimbursement applications for hospital pharmaceuticals in Denmark and has summarized the requirements and implications for the pharmaceutical industry. Economic analysis is now mandatory for submissions and along with medical effectiveness forms the basis for […]